Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
Clinical trial NCT02439216 · COMPLETED
Trial details
- NCT number
- NCT02439216
- Sponsor
- Catabasis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-01-12
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.